| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |